Form 4: Arcus Biosciences Chief Accounting Officer Sells Shares to Cover Tax Obligations

Arcus Biosciences' Chief Accounting Officer, Alexander Azoy, sold 2,969 shares of common stock to cover tax obligations related to vested Restricted Stock Units (RSUs).

Summary

• Alexander Azoy, Chief Accounting Officer of Arcus Biosciences, sold 2,969 shares of common stock on December 15, 2024.
• The sale was executed at a price of $16.08 per share.
• This transaction was a 'net settlement' by the company to cover tax withholding obligations associated with the vesting of previously granted RSUs.
• Following the transaction, Mr. Azoy directly owns 16,101 shares of Arcus Biosciences common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and tax obligations. It is neither positive nor negative for the company's outlook.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, common in publicly traded companies. It is not indicative of any change in the company's performance or outlook.

Comparison to Industry Standards

• Net settlement of RSUs for tax obligations is a standard practice in the industry.
• Many companies use this method to simplify the tax process for employees receiving equity compensation.
• The sale of shares by an officer to cover taxes is a common occurrence and does not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Arcus Biosciences, Alexander Azoy, Chief Accounting Officer, stock sale, Form 4, insider trading, RSU, tax obligations, net settlement